Please provide your email address to receive an email when new articles are posted on . Plozasiran demonstrated durable improvement in triglycerides, APOC3 and other lipid parameters for patients with ...
On August 31, 2020, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced the presentation of data from ongoing Phase 1/2 clinical trials of ARO-APOC3 and ARO-ANG3 at the European Society of ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has two late-stage cardiometabolic programs, ARO-APOC3 and ARO-ANG3. ARO-APOC3 is targeted to apolipoprotein C-III (APOC3), a component of very ...
BUFFALO, NY-March 20, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 5, entitled, ...
May 19, 2008 — Heavy, chronic use of marijuana causes increased levels of apolipoprotein C3 (apoC3), which in turn results in a major increase in triglyceride ...
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, ...
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARO-APOC3 for ...
Scientists have discovered several mutations in one gene that may safeguard a person from heart attacks. The mutations in this specific gene, known as APOC3, have been found to keep triglycerides at ...
SHANGHAI, March 17, 2025 /PRNewswire/ -- Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug ...
In this study, the authors identified the first genetic factor for NAFLD and demonstrated that lifestyle changes were capable of counteracting the genetic predisposition. These variants of APOC3 ...
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback